SOW
SPRY icon

State of Wyoming’s ARS Pharmaceuticals SPRY Stock Holding History

State of Wyoming’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-117
Closed -$762 – 1764
2023
Q1 		$762 Sell
117
-5
-4% -$38 ﹤0.01% 1541
2022
Q4 		$1.04K Buy
122
+89
+270% +$577 ﹤0.01% 1513
2022
Q3 		$0 Buy
+33
New +$163 ﹤0.01% 1907
2021
Q4 		– Sell
-14
Closed – – 1971
2021
Q3 		$0 Sell
14
-6
-30% -$148 ﹤0.01% 1328
2021
Q2 		$1K Buy
20
+11
+122% +$353 ﹤0.01% 1142
2021
Q1 		$0 Buy
+9
New +$426 ﹤0.01% 545

Other funds holding SPRY

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of Wyoming's SPRY Position: Q2 2023 in Review

State of Wyoming sold out of ARS Pharmaceuticals (SPRY) in Q2 2023, closing a stake of 117 shares — an estimated $762 sold.

State of Wyoming first reported a position in SPRY in Q1 2021 and held it in 6 quarters. The position peaked at $1.04K in Q4 2022. 92 funds tracked by Wall St. Rank hold SPRY as of Q2 2023.

  • State of Wyoming reported no remaining ARS Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 117 ARS Pharmaceuticals shares in Q2 2023, an estimated $762.
  • State of Wyoming first reported a position in ARS Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's ARS Pharmaceuticals position peaked at $1.04K in Q4 2022.
  • 92 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.